ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation (CRO), finishes the second half

VC firm Pivotal closes second $389M therapeutics fund to create companies and back public biotechs - San Francisco Biotechnology Network

Cotação ICON - ICLR, Ações NASDAQ

ICLR, Icon Plc, Dividend History

ICLR - Form 144 - Report of proposed sale of securities

PharmiWeb Recruiter Blog

ICLR, Icon Plc

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023 - San Francisco Biotechnology Network

Stock Market News 2023-12-18

Icon Plc Stock Quote, Stock Price for ICLR